Elite Pharmaceuticals Inc (ELTP): Total Assets
$138.29M
As of 2026-03-31
$139.67M
As of 2026-06-30
+50.1%
3-year compound annual growth
+39.5%
5-year compound annual growth
+15.9%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | $138.29M | +43.5% | 2026-06-29, Balance as of period end |
| 2025-03-31 | $96.39M | +15.2% | 2026-06-29, Balance as of period end |
| 2024-03-31 | $83.65M | +104.6% | 2025-06-30, Balance as of period end |
| 2023-03-31 | $40.90M | +16.4% | 2024-07-01, Balance as of period end |
| 2022-03-31 | $35.15M | +34.2% | 2023-06-29, Balance as of period end |
| 2021-03-31 | $26.19M | +4.9% | 2022-06-29, Balance as of period end |
| 2020-03-31 | $24.96M | +2.3% | 2021-06-14, Balance as of period end |
| 2019-03-31 | $24.40M | -21.0% | 2020-06-29, Balance as of period end |
| 2018-03-31 | $30.88M | -10.0% | 2019-06-21, Balance as of period end |
| 2017-03-31 | $34.31M | +8.3% | 2018-06-14, Balance as of period end |
| 2016-03-31 | $31.67M | +22.2% | 2017-06-14, Balance as of period end |
| 2015-03-31 | $25.92M | +6.6% | 2016-06-15, Balance as of period end |
| 2014-03-31 | $24.32M | +118.6% | 2015-06-15, Balance as of period end |
| 2013-03-31 | $11.13M | +7.9% | 2014-06-30, Balance as of period end |
| 2012-03-31 | $10.31M | -12.5% | 2013-06-21, Balance as of period end |
| 2011-03-31 | $11.79M | n/a | 2012-06-29, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Elite Pharmaceuticals Inc (ELTP) | 2026-03-31 | $138.29M | +43.5% |
| Macrogenics Inc (MGNX) | 2025-12-31 | $256.85M | -1.8% |
| Karyopharm Therapeutics Inc. (KPTI) | 2025-12-31 | $108.42M | -34.1% |
| Heron Therapeutics, Inc. (HRTX) | 2025-12-31 | $255.88M | +9.7% |
| Liquidia Corp (LQDA) | 2025-12-31 | $327.93M | +42.4% |
| Lifecore Biomedical, Inc. (LFCR) | 2025-05-25 | $239.34M | -5.8% |
| Syndax Pharmaceuticals Inc (SNDX) | 2025-12-31 | $529.71M | -26.9% |
| Phathom Pharmaceuticals, Inc. (PHAT) | 2025-12-31 | $259.15M | -31.5% |
| Cryoport, Inc. (CYRX) | 2025-12-31 | $764.99M | +8.7% |
Compare ELTP, MGNX, KPTI, HRTX side by side · Screen every company in Pharmaceutical Preparations ↗